138 related articles for article (PubMed ID: 29906298)
1. Synthesis, COX-1/2 inhibition and antioxidant activities of new oxicam analogues designed as potential chemopreventive agents.
Szczęśniak-Sięga B; Gębczak K; Gębarowski T; Maniewska J
Acta Biochim Pol; 2018; 65(2):199-207. PubMed ID: 29906298
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents.
Szczęśniak-Sięga BM; Wiatrak B; Czyżnikowska Ż; Janczak J; Wiglusz RJ; Maniewska J
Bioorg Chem; 2021 Jan; 106():104476. PubMed ID: 33250206
[TBL] [Abstract][Full Text] [Related]
3. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
[TBL] [Abstract][Full Text] [Related]
4. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond.
Xu S; Rouzer CA; Marnett LJ
IUBMB Life; 2014 Dec; 66(12):803-11. PubMed ID: 25537198
[TBL] [Abstract][Full Text] [Related]
5. Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide.
Świątek P; Glomb T; Dobosz A; Gębarowski T; Wojtkowiak K; Jezierska A; Panek JJ; Świątek M; Strzelecka M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008977
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and antioxidant properties of a novel resveratrol-salicylate hybrid analog.
Aldawsari FS; Aguiar RP; Wiirzler LA; Aguayo-Ortiz R; Aljuhani N; Cuman RK; Medina-Franco JL; Siraki AG; Velázquez-Martínez CA
Bioorg Med Chem Lett; 2016 Mar; 26(5):1411-5. PubMed ID: 26850006
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.
Thomas K; Moody TW; Jensen RT; Tong J; Rayner CL; Barnett NL; Fairfull-Smith KE; Ridnour LA; Wink DA; Bottle SE
Eur J Med Chem; 2018 Mar; 147():34-47. PubMed ID: 29421569
[TBL] [Abstract][Full Text] [Related]
8. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.
Lazer ES; Miao CK; Cywin CL; Sorcek R; Wong HC; Meng Z; Potocki I; Hoermann M; Snow RJ; Tschantz MA; Kelly TA; McNeil DW; Coutts SJ; Churchill L; Graham AG; David E; Grob PM; Engel W; Meier H; Trummlitz G
J Med Chem; 1997 Mar; 40(6):980-9. PubMed ID: 9083488
[TBL] [Abstract][Full Text] [Related]
9. [Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics].
Putilina MV; Teplova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):36-41. PubMed ID: 35904290
[TBL] [Abstract][Full Text] [Related]
10. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
[TBL] [Abstract][Full Text] [Related]
11. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
13. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
Chakraborty H; Roy S; Sarkar M
Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
[TBL] [Abstract][Full Text] [Related]
14. Scavenging of photogenerated ROS by Oxicams. Possible biological and environmental implications.
Ferrari GV; Natera J; Paulina Montaña M; Muñoz V; Gutiérrez EL; Massad W; Miskoski S; García NA
J Photochem Photobiol B; 2015 Dec; 153():233-9. PubMed ID: 26453988
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.
Arisawa M; Kasaya Y; Obata T; Sasaki T; Nakamura T; Araki T; Yamamoto K; Sasaki A; Yamano A; Ito M; Abe H; Ito Y; Shuto S
J Med Chem; 2012 Sep; 55(18):8152-63. PubMed ID: 22916727
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zebardast T; Zarghi A; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem Lett; 2009 Jun; 19(12):3162-5. PubMed ID: 19447036
[TBL] [Abstract][Full Text] [Related]
19. Meloxicam inhibits fipronil-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells.
Park JH; Park YS; Lee JB; Park KH; Paik MK; Jeong M; Koh HC
J Appl Toxicol; 2016 Jan; 36(1):10-23. PubMed ID: 25772694
[TBL] [Abstract][Full Text] [Related]
20. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families.
Van Antwerpen P; Nève J
Eur J Pharmacol; 2004 Aug; 496(1-3):55-61. PubMed ID: 15288575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
